The relationship between isolated hypertension with brain volumes in UK Biobank

Hypertension is a well‐established risk factor for cognitive impairment, brain atrophy, and dementia. However, the relationship of other types of hypertensions, such as isolated hypertension on brain health and its comparison to systolic‐diastolic hypertension (where systolic and diastolic measures are high), is still relatively unknown. Due to its increased prevalence, it is important to investigate the impact of isolated hypertension to help understand its potential impact on cognitive decline and future dementia risk. In this study, we compared a variety of global brain measures between participants with isolated hypertension to those with normal blood pressure (BP) or systolic‐diastolic hypertension using the largest cohort of healthy individuals.

[1]  L. Winchester,et al.  Associations Between Brain Volumes and Cognitive Tests with Hypertensive Burden in UK Biobank , 2021, Journal of Alzheimer's disease : JAD.

[2]  Danny J. Smith,et al.  Association between polygenic risk for Alzheimer’s disease, brain structure and cognitive abilities in UK Biobank , 2021, Neuropsychopharmacology.

[3]  Farzaneh A. Sorond,et al.  Hypertension-induced cognitive impairment: from pathophysiology to public health , 2021, Nature Reviews Nephrology.

[4]  Danny J. Smith,et al.  Association between polygenic risk for Alzheimer’s disease, brain structure and cognitive abilities in UK Biobank. , 2021 .

[5]  Sophie V. Eastwood,et al.  HbA1c and brain health across the entire glycaemic spectrum , 2021, Diabetes, obesity & metabolism.

[6]  F. Messerli,et al.  On cerebrotoxicity of antihypertensive therapy and risk factor cosmetics. , 2020, European heart journal.

[7]  K. Wartolowska,et al.  Midlife blood pressure is associated with the severity of white matter hyperintensities: analysis of the UK Biobank cohort study , 2020, European heart journal.

[8]  Naaheed Mukadam,et al.  Dementia prevention, intervention, and care: 2020 report of the Lancet Commission , 2020, The Lancet.

[9]  J. Pell,et al.  Association of SBP and BMI with cognitive and structural brain phenotypes in UK Biobank. , 2020, Journal of hypertension.

[10]  C. Sierra.  Hypertension and the Risk of Dementia , 2020, Frontiers in Cardiovascular Medicine.

[11]  Ji Hyun Han,et al.  Association of Low Blood Pressure with White Matter Hyperintensities in Elderly Individuals with Controlled Hypertension , 2020, Journal of stroke.

[12]  Nick C Fox,et al.  Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort (Insight 46): an epidemiological study , 2019, The Lancet Neurology.

[13]  M. Albert,et al.  Association of Midlife to Late-Life Blood Pressure Patterns With Incident Dementia. , 2019, JAMA.

[14]  Jackson T. Wright,et al.  Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions. , 2019, JAMA.

[15]  Thomas Kahan,et al.  [2018 ESC/ESH Guidelines for the management of arterial hypertension]. , 2019, Kardiologia polska.

[16]  2018 ESC/ESH Guidelines for the management of arterial hypertension. , 2019, Revista espanola de cardiologia.

[17]  Stuart J. Ritchie,et al.  Associations between vascular risk factors and brain MRI indices in UK Biobank , 2019, bioRxiv.

[18]  Ahmad R. Hariri,et al.  White matter hyperintensities are common in midlife and already associated with cognitive decline , 2019, bioRxiv.

[19]  David S. Bar-Shain,et al.  Association of Repeated Measurements With Blood Pressure Control in Primary Care , 2018, JAMA internal medicine.

[20]  R. Brook,et al.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Journal of the American Society of Hypertension : JASH.

[21]  C. DeCarli,et al.  Blood pressure from mid‐ to late life and risk of incident dementia , 2017, Neurology.

[22]  Ludovica Griffanti,et al.  Image processing and Quality Control for the first 10,000 brain imaging datasets from UK Biobank , 2017, NeuroImage.

[23]  Mark E Bastin,et al.  Ageing and brain white matter structure in 3,513 UK Biobank participants , 2016, Nature Communications.

[24]  C. Jack,et al.  Life-course blood pressure in relation to brain volumes , 2016, Alzheimer's & Dementia.

[25]  Joanna M Wardlaw,et al.  What are White Matter Hyperintensities Made of? , 2015, Journal of the American Heart Association.

[26]  Christos Davatzikos,et al.  Vascular Factors and Multiple Measures of Early Brain Health: CARDIA Brain MRI Study , 2015, PloS one.

[27]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[28]  G. Bakris,et al.  Isolated Diastolic Hypotension and Incident Heart Failure in Older Adults , 2011, Hypertension.

[29]  D. Aarsland,et al.  Hypertension is a potential risk factor for vascular dementia: systematic review , 2011, International journal of geriatric psychiatry.

[30]  H. Aizenstein,et al.  Regional grey matter shrinks in hypertensive individuals despite successful lowering of blood pressure , 2011, Journal of Human Hypertension.

[31]  R. Petersen,et al.  Prevention of dementia. , 2011, The Psychiatric clinics of North America.

[32]  S. Oparil,et al.  Treatment of isolated systolic hypertension in diabetes mellitus type 2 , 2006, Diabetes, obesity & metabolism.

[33]  Morris J. Brown,et al.  Increased Stroke Volume and Aortic Stiffness Contribute to Isolated Systolic Hypertension in Young Adults , 2005, Hypertension.

[34]  P. Verdecchia,et al.  Natural history of hypertension subtypes. , 2005, Circulation.

[35]  D. Levy,et al.  Predictors of New-Onset Diastolic and Systolic Hypertension: The Framingham Heart Study , 2005, Circulation.

[36]  E. Schiffrin.  Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. , 2004, American journal of hypertension.

[37]  J T O'Brien,et al.  Hippocampal atrophy, whole brain volume, and white matter lesions in older hypertensive subjects , 2004, Neurology.

[38]  Philip Scheltens,et al.  Midlife Blood Pressure and the Risk of Hippocampal Atrophy: The Honolulu Asia Aging Study , 2004, Hypertension.

[39]  A. Qureshi,et al.  Isolated and Borderline Isolated Systolic Hypertension Relative to Long-Term Risk and Type of Stroke: A 20-Year Follow-Up of the National Health and Nutrition Survey , 2002, Stroke.

[40]  S S Franklin,et al.  Predominance of Isolated Systolic Hypertension Among Middle-Aged and Elderly US Hypertensives: Analysis Based on National Health and Nutrition Examination Survey (NHANES) III , 2001, Hypertension.

[41]  J. Tuomilehto,et al.  Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial , 1998, The Lancet.

[42]  D. Levy,et al.  The natural history of borderline isolated systolic hypertension. , 1993, The New England journal of medicine.

[43]  J. Nie,et al.  A PRISMA-compliant meta-analysis , 2020 .

[44]  P. Sachdev,et al.  Midlife Hypertension and Alzheimer's Disease: A Systematic Review and Meta-Analysis. , 2019, Journal of Alzheimer's disease : JAD.

[45]  A. Toga,et al.  Mapping brain asymmetry , 2003, Nature Reviews Neuroscience.

[46]  G. Pickering.  The natural history of hypertension. , 1952, British medical bulletin.

[47]  Edinburgh Research Explorer Association between APOE e4 and white matter hyperintensity volume, but not total brain volume or white matter integrity , 2022 .

[48]  Edinburgh Research Explorer Associations between single and multiple cardiometabolic diseases and cognitive abilities in 474 129 UK Biobank participants , 2022 .